Serological testing for syphilis in the differential diagnosis of cognitive decline and polyneuropathy in geriatric patients

Abstract Background In the 19th century, neurosyphilis was the most frequent cause of dementia in Western Europe. Now dementia caused by syphilis has become rare in Germany. We studied whether routine testing of patients with cognitive abnormalities or neuropathy for antibodies against Treponema pal...

Full description

Bibliographic Details
Published in:BMC Geriatrics
Main Authors: Marija Djukic, Helmut Eiffert, Peter Lange, Ioanna Giotaki, Jana Seele, Roland Nau
Format: Article
Language:English
Published: BMC 2023-05-01
Subjects:
Online Access:https://doi.org/10.1186/s12877-023-03981-4
_version_ 1852677714546262016
author Marija Djukic
Helmut Eiffert
Peter Lange
Ioanna Giotaki
Jana Seele
Roland Nau
author_facet Marija Djukic
Helmut Eiffert
Peter Lange
Ioanna Giotaki
Jana Seele
Roland Nau
author_sort Marija Djukic
collection DOAJ
container_title BMC Geriatrics
description Abstract Background In the 19th century, neurosyphilis was the most frequent cause of dementia in Western Europe. Now dementia caused by syphilis has become rare in Germany. We studied whether routine testing of patients with cognitive abnormalities or neuropathy for antibodies against Treponema pallidum has therapeutic consequences in geriatric patients. Methods A Treponema pallidum electrochemiluminescence immunoassay (TP-ECLIA) is routinely performed in all in-patients treated at our institution with cognitve decline or neuropathy and no or insufficient previous diagnostic workup. Patients with a positive TP-ECLIA treated from October 2015 to January 2022 (76 months) were retrospectively evaluated. In cases of positive TP-ECLIA, further specific laboratory investigations were performed to assess whether antibiotic therapy was indicated. Results In 42 of 4116 patients (1.0%), TP-ECLIA detected antibodies directed against Treponema in serum. Specifity of these antibodies was ensured by immunoblot in 22 patients (11 × positiv, 11 × borderline values). Treponema-specific IgM was detectable in the serum of one patient, in 3 patients the Rapid Plasma Reagin (RPR) test, a modified Venereal Disease Research Laboratory test (VDRL), in serum was positiv. CSF analysis was performed in 10 patients. One patient had CSF pleocytosis. In 2 other patients, the Treponema-specific IgG antibody index was elevated. 5 patients received antibiotic therapy (4 × ceftriaxone 2 g/d i.v., 1 × doxycycline 300 mg/d p.o.). Conclusion In approx. 1‰ of patients with previously undiagnosed or not sufficiently diagnosed cognitive decline or neuropathy, the diagnostic workup for active syphilis resulted in a course of antibiotic treatment.
format Article
id doaj-art-e23a426cbb69485eb3082c19a30aebf9
institution Directory of Open Access Journals
issn 1471-2318
language English
publishDate 2023-05-01
publisher BMC
record_format Article
spelling doaj-art-e23a426cbb69485eb3082c19a30aebf92025-08-19T21:29:55ZengBMCBMC Geriatrics1471-23182023-05-012311910.1186/s12877-023-03981-4Serological testing for syphilis in the differential diagnosis of cognitive decline and polyneuropathy in geriatric patientsMarija Djukic0Helmut Eiffert1Peter Lange2Ioanna Giotaki3Jana Seele4Roland Nau5Institute of Neuropathology, Universitätsmedizin GöttingenInstitute of Neuropathology, Universitätsmedizin GöttingenDepartment of Neurology, Universitätsmedizin GöttingenDepartment of Neurology, Universitätsmedizin GöttingenInstitute of Neuropathology, Universitätsmedizin GöttingenInstitute of Neuropathology, Universitätsmedizin GöttingenAbstract Background In the 19th century, neurosyphilis was the most frequent cause of dementia in Western Europe. Now dementia caused by syphilis has become rare in Germany. We studied whether routine testing of patients with cognitive abnormalities or neuropathy for antibodies against Treponema pallidum has therapeutic consequences in geriatric patients. Methods A Treponema pallidum electrochemiluminescence immunoassay (TP-ECLIA) is routinely performed in all in-patients treated at our institution with cognitve decline or neuropathy and no or insufficient previous diagnostic workup. Patients with a positive TP-ECLIA treated from October 2015 to January 2022 (76 months) were retrospectively evaluated. In cases of positive TP-ECLIA, further specific laboratory investigations were performed to assess whether antibiotic therapy was indicated. Results In 42 of 4116 patients (1.0%), TP-ECLIA detected antibodies directed against Treponema in serum. Specifity of these antibodies was ensured by immunoblot in 22 patients (11 × positiv, 11 × borderline values). Treponema-specific IgM was detectable in the serum of one patient, in 3 patients the Rapid Plasma Reagin (RPR) test, a modified Venereal Disease Research Laboratory test (VDRL), in serum was positiv. CSF analysis was performed in 10 patients. One patient had CSF pleocytosis. In 2 other patients, the Treponema-specific IgG antibody index was elevated. 5 patients received antibiotic therapy (4 × ceftriaxone 2 g/d i.v., 1 × doxycycline 300 mg/d p.o.). Conclusion In approx. 1‰ of patients with previously undiagnosed or not sufficiently diagnosed cognitive decline or neuropathy, the diagnostic workup for active syphilis resulted in a course of antibiotic treatment.https://doi.org/10.1186/s12877-023-03981-4NeurosyphilisElectrochemiluminescence immunoassayImmunoblotCerebrospinal fluidTreponema-specific antibody index
spellingShingle Marija Djukic
Helmut Eiffert
Peter Lange
Ioanna Giotaki
Jana Seele
Roland Nau
Serological testing for syphilis in the differential diagnosis of cognitive decline and polyneuropathy in geriatric patients
Neurosyphilis
Electrochemiluminescence immunoassay
Immunoblot
Cerebrospinal fluid
Treponema-specific antibody index
title Serological testing for syphilis in the differential diagnosis of cognitive decline and polyneuropathy in geriatric patients
title_full Serological testing for syphilis in the differential diagnosis of cognitive decline and polyneuropathy in geriatric patients
title_fullStr Serological testing for syphilis in the differential diagnosis of cognitive decline and polyneuropathy in geriatric patients
title_full_unstemmed Serological testing for syphilis in the differential diagnosis of cognitive decline and polyneuropathy in geriatric patients
title_short Serological testing for syphilis in the differential diagnosis of cognitive decline and polyneuropathy in geriatric patients
title_sort serological testing for syphilis in the differential diagnosis of cognitive decline and polyneuropathy in geriatric patients
topic Neurosyphilis
Electrochemiluminescence immunoassay
Immunoblot
Cerebrospinal fluid
Treponema-specific antibody index
url https://doi.org/10.1186/s12877-023-03981-4
work_keys_str_mv AT marijadjukic serologicaltestingforsyphilisinthedifferentialdiagnosisofcognitivedeclineandpolyneuropathyingeriatricpatients
AT helmuteiffert serologicaltestingforsyphilisinthedifferentialdiagnosisofcognitivedeclineandpolyneuropathyingeriatricpatients
AT peterlange serologicaltestingforsyphilisinthedifferentialdiagnosisofcognitivedeclineandpolyneuropathyingeriatricpatients
AT ioannagiotaki serologicaltestingforsyphilisinthedifferentialdiagnosisofcognitivedeclineandpolyneuropathyingeriatricpatients
AT janaseele serologicaltestingforsyphilisinthedifferentialdiagnosisofcognitivedeclineandpolyneuropathyingeriatricpatients
AT rolandnau serologicaltestingforsyphilisinthedifferentialdiagnosisofcognitivedeclineandpolyneuropathyingeriatricpatients